Search Results - "Vo, Trang T."

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    INPP4B Is a Tumor Suppressor in the Context of PTEN Deficiency by Vo, Thanh-Trang T, Fruman, David A

    Published in Cancer discovery (01-07-2015)
    “…Enzymes (PI3K and PTEN) controlling cellular levels of 3-phosphorylated phosphoinositides are known as important drivers or suppressors of tumorigenesis in…”
    Get more information
    Journal Article
  2. 2

    mTOR inhibition enhances efficacy of dasatinib in ABL -rearranged Ph-like B-ALL by Gotesman, Moran, Vo, Thanh-Trang T, Herzog, Lee-Or, Tea, Tiffeny, Mallya, Sharmila, Tasian, Sarah K, Konopleva, Marina, Fruman, David A

    Published in Oncotarget (19-01-2018)
    “…High-risk subtypes of B-cell acute lymphoblastic leukemia (B-ALL) include Philadelphia chromosome-positive (Ph+) B-ALL driven by the oncogene and a more…”
    Get full text
    Journal Article
  3. 3

    Scavenger receptor class F member 2 (SCARF2) as a novel therapeutic target in glioblastoma by Kim, Chaeyeong, Kong, Gyeyeong, Lee, Hyunji, Tran, Quangdon, Vo, Thuy-Trang T., Kwon, So Hee, Park, Jisoo, Kim, Seon-Hwan, Park, Jongsun

    Published in Toxicological research (Seoul) (01-04-2022)
    “…Scavenger receptor class F member 2 (SCARF2) is expressed by endothelial cells with very large cytoplasmic domains and is the second isotype, also known as…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Functional characteristics and research trends of PDE11A in human diseases (Review) by Kong, Gyeyeong, Lee, Hyunji, Vo, Thuy-trang T, Juang, Uijin, Kwon, So Hee, Park, Jisoo, Park, Jongsun, Kim, Seon-Hwan

    Published in Molecular medicine reports (01-10-2022)
    “…cAMP and cGMP are important secondary messengers involved in cell regulation and metabolism driven by the G protein-coupled receptor. cAMP is converted via…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Exploring scavenger receptor class F member 2 and the importance of scavenger receptor family in prediagnostic diseases by Vo, Thuy-Trang T., Kong, Gyeyeong, Kim, Chaeyeong, Juang, Uijin, Gwon, Suhwan, Jung, Woohyeong, Nguyen, Huonggiang, Kim, Seon-Hwan, Park, Jongsun

    Published in Toxicological research (Seoul) (01-07-2023)
    “…Scavenger Receptor Class F Member 2 ( SCARF2 ), also known as the Type F Scavenger Receptor Family gene, encodes for Scavenger Receptor Expressed by…”
    Get full text
    Journal Article
  8. 8

    AXL is required for hypoxia-mediated hypoxia-inducible factor-1 alpha function in glioblastoma by Vo, Thuy-Trang T., Tran, Quangdon, Hong, Youngeun, Lee, Hyunji, Cho, Hyeonjeong, Kim, Minhee, Park, Sungjin, Kim, Chaeyeong, Bayarmunkh, Choinyam, Boldbaatar, Damdindorj, Kwon, So Hee, Park, Jisoo, Kim, Seon-Hwan, Park, Jongsun

    Published in Toxicological research (Seoul) (01-10-2023)
    “…Glioblastoma (GBM) is the most aggressive type of central nervous system tumor. Molecular targeting may be important when developing efficient GBM treatment…”
    Get full text
    Journal Article
  9. 9

    mTORC1 Inhibition Induces Resistance to Methotrexate and 6-Mercaptopurine in Ph + and Ph-like B-ALL by Vo, Thanh-Trang T, Lee, J Scott, Nguyen, Duc, Lui, Brandon, Pandori, William, Khaw, Andrew, Mallya, Sharmila, Lu, Mengrou, Müschen, Markus, Konopleva, Marina, Fruman, David A

    Published in Molecular cancer therapeutics (01-09-2017)
    “…Elevated activity of mTOR is associated with poor prognosis and higher incidence of relapse in B-cell acute lymphoblastic leukemia (B-ALL). Thus, ongoing…”
    Get full text
    Journal Article
  10. 10

    Profiles of Urine Drug Test in Clinical Pain Patients vs Pain Research Study Subjects by Lee, Cheng-ting, Vo, Trang T., Cohen, Abigail S., Ahmed, Shihab, Zhang, Yi, Mao, Jianren, Chen, Lucy

    Published in Pain medicine (Malden, Mass.) (01-04-2016)
    “…Abstract Objective. To examine similarities and differences in urine drug test (UDT) results in clinical pain patients and pain subjects participating in pain…”
    Get full text
    Journal Article
  11. 11

    Abstract 3851: Synergy between statins and BCL-2 inhibitors in blood cancers by Lee, Jong-Hoon S., Vo, Thanh-Trang T., Fruman, David A.

    Published in Cancer research (Chicago, Ill.) (15-07-2016)
    “…BCL-2 is a key pro-survival protein that is highly expressed in many leukemias and lymphomas. ABT-199 (venetoclax) is a small molecule inhibitor of BCL-2 that…”
    Get full text
    Journal Article
  12. 12

    Statins Potentiate the Cytotoxic Effect of ABT-199 in Diffuse Large B Cell Lymphoma by Fruman, David A., Lee, Jong-Hoon Scott, Vo, Thanh-Trang T, Bhatt, Shruti, Schatz, Jonathan H., Letai, Anthony

    Published in Blood (02-12-2016)
    “…BCL-2 is a key pro-survival protein that is highly expressed in many leukemias and lymphomas. ABT-199 (venetoclax) is a small molecule inhibitor of BCL-2 that…”
    Get full text
    Journal Article
  13. 13

    mTOR Kinase Inhibitors Enhance Efficacy of TKIs in Preclinical Models of Ph-like B-ALL by Gotesman, Moran, Vo, Thanh-Trang T, Mallya, Sharmila, Zhang, Qi, Shi, Ce, Müschen, Markus, Weinstock, David M., Mullighan, Charles, Tasian, Sarah K, Konopleva, Marina, Fruman, David A.

    Published in Blood (02-12-2016)
    “…Background and Rationale: B-lymphoblastic leukemia (B-ALL) is the most common cancer of childhood. While event-free survival (EFS) exceeds 85% for most…”
    Get full text
    Journal Article
  14. 14

    On discarding low quality produce by Nguyen, D, Vo, T.T

    Published in American journal of agricultural economics (01-08-1985)
    “…Extract: This paper considers a model of optimal culling in which demand is generally nonlinear. We show that the shape of the break-even quality price change…”
    Get full text
    Journal Article
  15. 15

    Measuring Mitochondrial Apoptotic Priming by BH3 Profiling Predicts Induction Outcome for Acute Myeloid Leukemia Patients by Vo, Thanh-Trang T, Stone, Richard, DeAngelo, Daniel J, Frattini, Mark G., Letai, Anthony G.

    Published in Blood (18-11-2011)
    “…Abstract 239 The mechanistic basis for differential response to induction therapy in AML is poorly understood. Our laboratory has found that primary normal and…”
    Get full text
    Journal Article